PRE-surgical Metformin In Uterine Malignancy (PREMIUM): a Multi-Center, Randomized Double-Blind, Placebo-Controlled Phase III Trial

PURPOSE: Endometrioid endometrial cancer is strongly associated with obesity and insulin resistance. Metformin,an insulin sensitizer, reduces endometrial tumor growth in vitro. Presurgical window studies allow rapid in vivo assessment of antitumor activity. Previous window studies found metformin re...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Clin Cancer Res
Main Authors: Kitson, Sarah J., Maskell, Zoe, Sivalingam, Vanitha N., Allen, Jennifer L., Ali, Saad, Burns, Sean, Gilmour, Kyle, Latheef, Rahamatulla, Slade, Richard J., Pemberton, Philip W., Shaw, Joseph, Ryder, W. David, Kitchener, Henry C., Crosbie, Emma J.
Formato: Artigo
Idioma:Inglês
Publicado: 2019
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6586555/
https://ncbi.nlm.nih.gov/pubmed/30563932
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-18-3339
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares